Elias Zerhouni - Articles and news items

Sanofi and Regeneron’s Dupilumab named “Clinical Advance of the Year” by Scrip Intelligence

Industry news / 25 November 2013 / Sanofi

Dupilumab is a fully-human monoclonal antibody that is in clinical development for treatment of asthma, atopic dermatitis, and nasal polyposis…


Sanofi appoints Dr. Gary J. Nabel as Chairman of the SDSAC

Industry news, News / 7 January 2013 / Sanofi

“I am delighted that Dr. Gary Nabel will continue to make this Council a vital part of our efforts…”


Sanofi appoints Dr. Gary J. Nabel as Chief Scientific Officer

Industry news, News / 14 November 2012 / Sanofi

Sanofi is pleased to announce the appointment of Dr. Gary J. Nabel…


Sanofi appoints Dr. Paul Chew, Chief Medical Officer and Head of Global Medical Affairs

Industry news, News / 1 October 2012 / Sanofi

Sanofi is pleased to announce the appointment of Dr. Paul Chew…

Sanofi and TB Alliance announce collaboration to accelerate new treatments against tuberculosis

Industry news, News / 20 September 2012 / Sanofi

Sanofi and TB Alliance have announced a new research collaboration agreement…

Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes

Industry news, News / 19 June 2012 / Sanofi

Sanofi and the Joslin Diabetes Center announced a new collaboration…

Sanofi and Michael J. Fox Foundation collaborate on potential new treatment for Parkinson’s disease

Industry news, News / 19 April 2012 / Sanofi

Fox Foundation to sponsor a clinical trial to study Sanofi compound…

Sanofi and the Institut Pasteur create four prestigious awards to support innovative biomedical research

Industry news, News / 27 February 2012 / Sanofi

The creation of the Sanofi-Institut Pasteur Awards announced…

Sanofi and Venture Capital Firms, Third Rock Ventures and Greylock Partners, jointly launch Warp Drive Bio

Industry news, News / 10 January 2012 / Sanofi

Sanofi is co-investing in Warp Drive Bio, an innovative start-up biotechnology company…

Sanofi Pasteur

Sanofi Pasteur acquires exclusive, worldwide license for acne vaccine and treatment

Industry news, News / 21 September 2011 / Sanofi Pasteur

The pre-clinical vaccine was developed by researchers at the University of California…

Sanofi and Regeneron report positive Phase 2b trial results with sarilumab in rheumatoid arthritis

Industry news, News / 12 July 2011 / Sanofi

Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials…

  • Page 1 of 2
  • 1
  • 2
  • >


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...